Novo Nordisk AS
A3EU6F
DK0062498333 //
Quelle: CPH Equities: 12:27:48
259,10 DKK
Kurs
Kurs
1,05%
Diff. Vortag in %
Diff. Vortag in %
224,25 DKK
52 Wochen Tief
52 Wochen Tief
409,95 DKK
52 Wochen Hoch
52 Wochen Hoch
- Neutral
- Seit dem 25.09.2026
- Informationen von thescreener.com
Tools
Fundamentalanalyse
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 0 Monate | 0 Monate | 259,10 225 | 259,10 | 225 | 13,160942 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 05.10.2026 0 Monate | 05.10.2026 | 0 Monate | 259,10 275 | 259,10 | 275 | 6,136627 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 259,10 245 | 259,10 | 245 | 5,441914 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 259,10 245 | 259,10 | 245 | 5,441914 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 22.09.2026 12 Monate | 22.09.2026 | 12 Monate | 259,10 305 | 259,10 | 305 | 17,715168 | BERENBERG | ||
| Novo Nordisk AS | 21.09.2026 12 Monate | 21.09.2026 | 12 Monate | 259,10 285 | 259,10 | 285 | 9,99614 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 21.09.2026 0 Monate | 21.09.2026 | 0 Monate | 259,10 275 | 259,10 | 275 | 6,136627 | JPMORGAN | ||
| Novo Nordisk AS | 21.09.2026 12 Monate | 21.09.2026 | 12 Monate | 259,10 275 | 259,10 | 275 | 6,136627 | JEFFERIES | ||
| Novo Nordisk AS | 21.09.2026 0 Monate | 21.09.2026 | 0 Monate | 259,10 260 | 259,10 | 260 | 0,347356 | JPMORGAN | ||
| Novo Nordisk AS | 21.09.2026 0 Monate | 21.09.2026 | 0 Monate | 259,10 332 | 259,10 | 332 | 28,135855 | UBS | ||
| Novo Nordisk AS | 16.09.2026 0 Monate | 16.09.2026 | 0 Monate | 259,10 332 | 259,10 | 332 | 28,135855 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 259,10 265 | 259,10 | 265 | 2,277113 | DEUTSCHE BANK RESEARCH |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 11.09.2026 12 Monate | 11.09.2026 | 12 Monate | 259,10 250 | 259,10 | 250 | 3,512157 | MORGAN STANLEY | ||
| Novo Nordisk AS | 07.09.2026 12 Monate | 07.09.2026 | 12 Monate | 259,10 300 | 259,10 | 300 | 15,785411 | BARCLAYS | ||
| Novo Nordisk AS | 03.09.2026 0 Monate | 03.09.2026 | 0 Monate | 259,10 275 | 259,10 | 275 | 6,136627 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 259,10 265 | 259,10 | 265 | 2,277113 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 259,10 265 | 259,10 | 265 | 2,277113 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 12 Monate | 12 Monate | 259,10 290 | 259,10 | 290 | 11,925897 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 24.08.2026 0 Monate | 24.08.2026 | 0 Monate | 259,10 275 | 259,10 | 275 | 6,136627 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 259,10 290 | 259,10 | 290 | 11,925897 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 11.08.2026 0 Monate | 11.08.2026 | 0 Monate | 259,10 305 | 259,10 | 305 | 17,715168 | BERENBERG | ||
| Novo Nordisk AS | 07.08.2026 0 Monate | 07.08.2026 | 0 Monate | 259,10 | 259,10 | -- | DZ BANK | |||
| Novo Nordisk AS | 06.08.2026 12 Monate | 06.08.2026 | 12 Monate | 259,10 285 | 259,10 | 285 | 9,99614 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 06.08.2026 12 Monate | 06.08.2026 | 12 Monate | 259,10 290 | 259,10 | 290 | 11,925897 | DEUTSCHE BANK RESEARCH |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 05.08.2026 0 Monate | 05.08.2026 | 0 Monate | 259,10 200 | 259,10 | 200 | 22,809726 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 05.08.2026 0 Monate | 05.08.2026 | 0 Monate | 259,10 332 | 259,10 | 332 | 28,135855 | UBS | ||
| Novo Nordisk AS | 05.08.2026 12 Monate | 05.08.2026 | 12 Monate | 259,10 310 | 259,10 | 310 | 19,644925 | BARCLAYS | ||
| Novo Nordisk AS | 04.08.2026 12 Monate | 04.08.2026 | 12 Monate | 259,10 285 | 259,10 | 285 | 9,99614 | JEFFERIES | ||
| Novo Nordisk AS | 04.08.2026 0 Monate | 04.08.2026 | 0 Monate | 259,10 332 | 259,10 | 332 | 28,135855 | UBS | ||
| Novo Nordisk AS | 31.07.2026 0 Monate | 31.07.2026 | 0 Monate | 259,10 250 | 259,10 | 250 | 3,512157 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 259,10 290 | 259,10 | 290 | 11,925897 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 10.07.2026 0 Monate | 10.07.2026 | 0 Monate | 259,10 332 | 259,10 | 332 | 28,135855 | UBS | ||
| Novo Nordisk AS | 29.06.2026 12 Monate | 29.06.2026 | 12 Monate | 259,10 285 | 259,10 | 285 | 9,99614 | JEFFERIES | ||
| Novo Nordisk AS | 28.06.2026 0 Monate | 28.06.2026 | 0 Monate | 259,10 250 | 259,10 | 250 | 3,512157 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 259,10 290 | 259,10 | 290 | 11,925897 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 16.06.2026 0 Monate | 16.06.2026 | 0 Monate | 259,10 325 | 259,10 | 325 | 25,434195 | BERENBERG |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 0 Monate | 0 Monate | 259,10 290 | 259,10 | 290 | 11,925897 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 08.06.2026 0 Monate | 08.06.2026 | 0 Monate | 259,10 250 | 259,10 | 250 | 3,512157 | JPMORGAN | ||
| Novo Nordisk AS | 08.06.2026 0 Monate | 08.06.2026 | 0 Monate | 259,10 250 | 259,10 | 250 | 3,512157 | JPMORGAN | ||
| Novo Nordisk AS | 03.06.2026 12 Monate | 03.06.2026 | 12 Monate | 259,10 305 | 259,10 | 305 | 17,715168 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 29.05.2026 0 Monate | 29.05.2026 | 0 Monate | 259,10 270 | 259,10 | 270 | 4,20687 | JEFFERIES | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 259,10 290 | 259,10 | 290 | 11,925897 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 259,10 290 | 259,10 | 290 | 11,925897 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 18.05.2026 0 Monate | 18.05.2026 | 0 Monate | 259,10 300 | 259,10 | 300 | 15,785411 | BARCLAYS | ||
| Novo Nordisk AS | 12.05.2026 12 Monate | 12.05.2026 | 12 Monate | 259,10 270 | 259,10 | 270 | 4,20687 | JEFFERIES | ||
| Novo Nordisk AS | 11.05.2026 12 Monate | 11.05.2026 | 12 Monate | 259,10 175 | 259,10 | 175 | 32,45851 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 259,10 290 | 259,10 | 290 | 11,925897 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 259,10 290 | 259,10 | 290 | 11,925897 | DEUTSCHE BANK RESEARCH |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 259,10 | 259,10 | -- | DZ BANK | |||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 259,10 300 | 259,10 | 300 | 15,785411 | BARCLAYS | ||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 259,10 332 | 259,10 | 332 | 28,135855 | UBS | ||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 259,10 250 | 259,10 | 250 | 3,512157 | JPMORGAN | ||
| Novo Nordisk AS | 06.05.2026 12 Monate | 06.05.2026 | 12 Monate | 259,10 263 | 259,10 | 263 | 1,50521 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 259,10 250 | 259,10 | 250 | 3,512157 | JPMORGAN | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 259,10 175 | 259,10 | 175 | 32,45851 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 259,10 300 | 259,10 | 300 | 15,785411 | BARCLAYS | ||
| Novo Nordisk AS | 29.04.2026 12 Monate | 29.04.2026 | 12 Monate | 259,10 250 | 259,10 | 250 | 3,512157 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 259,10 275 | 259,10 | 275 | 6,136627 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 20.04.2026 0 Monate | 20.04.2026 | 0 Monate | 259,10 270 | 259,10 | 270 | 4,20687 | JEFFERIES | ||
| Novo Nordisk AS | 20.04.2026 0 Monate | 20.04.2026 | 0 Monate | 259,10 250 | 259,10 | 250 | 3,512157 | JPMORGAN |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 15.04.2026 12 Monate | 15.04.2026 | 12 Monate | 259,10 270 | 259,10 | 270 | 4,20687 | JEFFERIES | ||
| Novo Nordisk AS | 09.04.2026 0 Monate | 09.04.2026 | 0 Monate | 259,10 332 | 259,10 | 332 | 28,135855 | UBS | ||
| Novo Nordisk AS | 01.04.2026 0 Monate | 01.04.2026 | 0 Monate | 259,10 270 | 259,10 | 270 | 4,20687 | BARCLAYS | ||
| Novo Nordisk AS | 31.03.2026 12 Monate | 31.03.2026 | 12 Monate | 259,10 263 | 259,10 | 263 | 1,50521 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 30.03.2026 0 Monate | 30.03.2026 | 0 Monate | 259,10 270 | 259,10 | 270 | 4,20687 | BARCLAYS | ||
| Novo Nordisk AS | 29.03.2026 0 Monate | 29.03.2026 | 0 Monate | 259,10 250 | 259,10 | 250 | 3,512157 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 259,10 275 | 259,10 | 275 | 6,136627 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 26.03.2026 0 Monate | 26.03.2026 | 0 Monate | 259,10 270 | 259,10 | 270 | 4,20687 | BARCLAYS | ||
| Novo Nordisk AS | 25.03.2026 0 Monate | 25.03.2026 | 0 Monate | 259,10 250 | 259,10 | 250 | 3,512157 | JPMORGAN | ||
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 259,10 270 | 259,10 | 270 | 4,20687 | JEFFERIES | ||
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 259,10 270 | 259,10 | 270 | 4,20687 | BARCLAYS | ||
| Novo Nordisk AS | 11.03.2026 0 Monate | 11.03.2026 | 0 Monate | 259,10 300 | 259,10 | 300 | 15,785411 | BERENBERG |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 09.03.2026 0 Monate | 09.03.2026 | 0 Monate | 259,10 250 | 259,10 | 250 | 3,512157 | JPMORGAN | ||
| Novo Nordisk AS | 06.03.2026 12 Monate | 06.03.2026 | 12 Monate | 259,10 270 | 259,10 | 270 | 4,20687 | BARCLAYS | ||
| Novo Nordisk AS | 02.03.2026 12 Monate | 02.03.2026 | 12 Monate | 259,10 260 | 259,10 | 260 | 0,347356 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 02.03.2026 0 Monate | 02.03.2026 | 0 Monate | 259,10 270 | 259,10 | 270 | 4,20687 | BARCLAYS | ||
| Novo Nordisk AS | 27.02.2026 12 Monate | 27.02.2026 | 12 Monate | 259,10 270 | 259,10 | 270 | 4,20687 | BARCLAYS | ||
| Novo Nordisk AS | 24.02.2026 12 Monate | 24.02.2026 | 12 Monate | 259,10 400 | 259,10 | 400 | 54,380548 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 24.02.2026 0 Monate | 24.02.2026 | 0 Monate | 259,10 250 | 259,10 | 250 | 3,512157 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 259,10 400 | 259,10 | 400 | 54,380548 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 259,10 332 | 259,10 | 332 | 28,135855 | UBS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 259,10 340 | 259,10 | 340 | 31,223466 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 259,10 275 | 259,10 | 275 | 6,136627 | JEFFERIES | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 259,10 350 | 259,10 | 350 | 35,08298 | JPMORGAN |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 259,10 340 | 259,10 | 340 | 31,223466 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 259,10 275 | 259,10 | 275 | 6,136627 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 259,10 250 | 259,10 | 250 | 3,512157 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 259,10 270 | 259,10 | 270 | 4,20687 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 259,10 340 | 259,10 | 340 | 31,223466 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 259,10 340 | 259,10 | 340 | 31,223466 | BARCLAYS | ||
| Novo Nordisk AS | 17.02.2026 0 Monate | 17.02.2026 | 0 Monate | 259,10 340 | 259,10 | 340 | 31,223466 | BARCLAYS | ||
| Novo Nordisk AS | 12.02.2026 0 Monate | 12.02.2026 | 0 Monate | 259,10 340 | 259,10 | 340 | 31,223466 | BARCLAYS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 259,10 400 | 259,10 | 400 | 54,380548 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 259,10 275 | 259,10 | 275 | 6,136627 | JEFFERIES | ||
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 259,10 360 | 259,10 | 360 | 38,942493 | BERENBERG | ||
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 259,10 360 | 259,10 | 360 | 38,942493 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 259,10 360 | 259,10 | 360 | 38,942493 | BARCLAYS | ||
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 259,10 350 | 259,10 | 350 | 35,08298 | JPMORGAN | ||
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 259,10 332 | 259,10 | 332 | 28,135855 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 259,10 475 | 259,10 | 475 | 83,326901 | DEUTSCHE BANK RESEARCH |
News
Aktuell
| Datum | Terminart Information | Information |
|---|---|---|
| 04.11.2026 | Bericht zum 3. Quartal Novo Nordisk A/S: Third quarter 2026 | Novo Nordisk A/S: Third quarter 2026 |
Anlage-Spezial Europäische Aktien
28.05.2026
Novo Nordisk: KI und Amycretin zünden nächste Pipeline-Stufe
KI beschleunigt die Wirkstoffforschung von Novo Nordisk erheblich. Neue Tabletten wie Amycretin sichern dabei die künftige Marktdominanz ab.
DZ BANK Produktauswahl
Optionsscheine Classic Long
Produktauswahl : Basiswert Novo Nordisk AS
Min
Abstand zum Basispreis in %
Max
Discount Classic
Produktauswahl : Basiswert Novo Nordisk AS
Min
Discount in %
Max
Endlos Turbos Long
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Optionsscheine Classic Short
Produktauswahl : Basiswert Novo Nordisk AS
Min
Abstand zum Basispreis in %
Max
Endlos Turbos Short
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Knock Out Map
- wertpapiere@dzbank.de (069) 7447-7035
-
DZ BANK AG, Platz der Republik,
60265 Frankfurt / M